{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:34:52Z","timestamp":1781037292239,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014232","name":"Norwegian Directorate of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.brainres.2021.147481","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T17:26:06Z","timestamp":1618593966000},"page":"147481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Serum tyrosine is associated with better cognition in Lewy body dementia"],"prefix":"10.1016","volume":"1765","author":[{"given":"Adrian","family":"McCann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Magne","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein-Erik H.","family":"Solvang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Erik","family":"Nordrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse M.","family":"Giil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.brainres.2021.147481_b0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000165917","article-title":"Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria","volume":"26","author":"Aarsland","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"4","key":"10.1016\/j.brainres.2021.147481_b0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000087446","article-title":"The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort","volume":"25","author":"Bennett","year":"2005","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.brainres.2021.147481_b0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-016-1517-6","article-title":"MMSE and MoCA in Parkinson\u2019s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study","volume":"123","author":"Biundo","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2021.147481_b0020","unstructured":"Brady, S., Basic neurochemistry: principles of molecular, cellular, and medical neurobiology. 2011: Academic Press."},{"issue":"8","key":"10.1016\/j.brainres.2021.147481_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135437","article-title":"Reliability of serum metabolites over a two-year period: a targeted metabolomic approach in fasting and non-fasting samples from EPIC","volume":"10","author":"Carayol","year":"2015","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.brainres.2021.147481_b0030","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","article-title":"Inverted-U\u2013shaped dopamine actions on human working memory and cognitive control","volume":"69","author":"Cools","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.brainres.2021.147481_b0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus\u2013norepinephrine system and related circuitry in Parkinson's disease-related dementia","volume":"84","author":"Del Tredici","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainres.2021.147481_b0040","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0197-4580(97)00067-5","article-title":"Diagnosis and staging of Alzheimer disease","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2021.147481_b0045","series-title":"Amino Acid Availability and Brain Function in Health and Disease","first-page":"137","article-title":"Tryptophan availability and serotonin synthesis in brain","author":"Fernstrom","year":"1988"},{"issue":"3","key":"10.1016\/j.brainres.2021.147481_b0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00726-012-1330-y","article-title":"Large neutral amino acids: dietary effects on brain neurochemistry and function","volume":"45","author":"Fernstrom","year":"2013","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.brainres.2021.147481_b0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12264-007-0008-z","article-title":"Effect of \u03b1-synuclein on the promoter activity of tyrosine hydroxylase gene","volume":"23","author":"Gao","year":"2007","journal-title":"Neuroscience bulletin"},{"key":"10.1016\/j.brainres.2021.147481_b0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","article-title":"Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry","volume":"102","author":"Gonzalez-Dominguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"18","key":"10.1016\/j.brainres.2021.147481_b0065","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/elps.201400544","article-title":"High throughput multiorgan metabolomics in the APP\/PS1 mouse model of Alzheimer's disease","volume":"36","author":"Gonzalez-Dominguez","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.brainres.2021.147481_b0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease","volume":"107","author":"Gonzalez-Dominguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.brainres.2021.147481_b0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0024-3205(82)90596-3","article-title":"Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease","volume":"30","author":"Growdon","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2021.147481_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919877883","article-title":"Kynurenines, neuropsychiatric symptoms, and cognitive prognosis in patients with mild dementia","volume":"12","author":"Hafstad Solvang","year":"2019","journal-title":"Int. J. Tryptophan Res."},{"issue":"2","key":"10.1016\/j.brainres.2021.147481_b0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1041610200006359","article-title":"Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis","volume":"12","author":"Han","year":"2000","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.brainres.2021.147481_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.03.008","article-title":"Behavioral and cognitive effects of tyrosine intake in healthy human adults","volume":"133","author":"Hase","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"12","key":"10.1016\/j.brainres.2021.147481_b0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/jnnp.2006.109074","article-title":"Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination","volume":"78","author":"Hensel","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.brainres.2021.147481_b0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.300.7.823","article-title":"Within-person across-neuropsychological test variability and incident dementia","volume":"300","author":"Holtzer","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.brainres.2021.147481_b0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3233\/JAD-180879","article-title":"Novel blood biomarkers that correlate with cognitive performance and hippocampal volumetry: potential for early diagnosis of Alzheimer's Disease","volume":"67","author":"Hudd","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.brainres.2021.147481_b0110","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","article-title":"Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease","volume":"11","author":"Jouvet","year":"2000","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.brainres.2021.147481_b0115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00426-017-0957-4","article-title":"Food for thought: association between dietary tyrosine and cognitive performance in younger and older adults","volume":"83","author":"Kuhn","year":"2019","journal-title":"Psychol. Res."},{"issue":"2 SUPPL. 1","key":"10.1016\/j.brainres.2021.147481_b0120","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Levey","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.brainres.2021.147481_b0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.talanta.2013.09.019","article-title":"Ultrahigh resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models","volume":"118","author":"Lin","year":"2014","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.brainres.2021.147481_b0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"issue":"12","key":"10.1016\/j.brainres.2021.147481_b0135","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2021.147481_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.brainres.2021.147481_b0145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.brainres.2021.147481_b0150","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1021\/acs.analchem.6b02325","article-title":"Combined measurement of 6 fat-soluble vitamins and 26 water-soluble functional vitamin markers and amino acids in 50 \u03bcL of serum or plasma by high-throughput mass spectrometry","volume":"88","author":"Midttun","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.brainres.2021.147481_b0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.bi.40.070171.002341","article-title":"Biochemistry of catecholamines","volume":"40","author":"Molinoff","year":"1971","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.brainres.2021.147481_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.brainres.2021.147481_b0165","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/aws234","article-title":"Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies","volume":"135","author":"Schneider","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.brainres.2021.147481_b0170","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3233\/JAD-170274","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology","volume":"59","author":"Skogseth","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"6645","key":"10.1016\/j.brainres.2021.147481_b0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.brainres.2021.147481_b0180","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological management of Lewy body dementia: a systematic review and meta-analysis","volume":"172","author":"Stinton","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.brainres.2021.147481_b0185","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/bioinformatics\/btn209","article-title":"fdrtool: a versatile R package for estimating local and tail area-based false discovery rates","volume":"24","author":"Strimmer","year":"2008","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.brainres.2021.147481_b0190","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","article-title":"Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells","volume":"99","author":"Tehranian","year":"2006","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.brainres.2021.147481_b0195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","article-title":"Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: a prospective study in eight cohorts","volume":"14","author":"Tynkkynen","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.brainres.2021.147481_b0200","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2021.147481_b0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MN:31:1-3:243","article-title":"\u03b1-Synuclein and dopamine metabolism","volume":"31","author":"Yu","year":"2005","journal-title":"Mol. Neurobiol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321003383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321003383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:17:15Z","timestamp":1757787435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899321003383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"alternative-id":["S0006899321003383"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147481","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum tyrosine is associated with better cognition in Lewy body dementia","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147481"}}